Erin Burkhart

Erin Burkhart

Comptroller/Controller/Auditor at GILEAD SCIENCES, INC.

Net worth: 811 971 $ as of 31/05/2026

57 year
Health Technology
Consumer Services

Profile

Erin E.
Burkhart
is Chief Accounting Officer, Senior VP & Controller at Gilead Sciences, Inc. starting in 2025.
Former roles include Chief Accounting Officer & Group Vice President at BioMarin Pharmaceutical, Inc. from 2022 to 2025, and Associate VP-US Gross-to-Net Business Analysis at Eli Lilly & Co. from 2021 to 2022.
Education includes undergraduate studies at Butler University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/05/2025 14,173 ( 0.01% ) 811 971 $ 31/05/2026

Erin Burkhart active positions

CompaniesPositionStart
GILEAD SCIENCES, INC. Comptroller/Controller/Auditor 22/09/2025

Former positions of Erin Burkhart

CompaniesPositionEnd
BIOMARIN PHARMACEUTICAL INC. Comptroller/Controller/Auditor 02/09/2025
ELI LILLY AND COMPANY Corporate Officer/Principal 01/04/2022
See the detail of Erin Burkhart's experience

Training of Erin Burkhart

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Health Technology

Health Technology

Consumer Services